182 related articles for article (PubMed ID: 28731284)
1. The RNA-binding protein HuR inhibits expression of CCL5 and limits recruitment of macrophages into tumors.
Brauß TF; Winslow S; Lampe S; Scholz A; Weigert A; Dehne N; von Stedingk K; Schmid T; Brüne B
Mol Carcinog; 2017 Dec; 56(12):2620-2629. PubMed ID: 28731284
[TBL] [Abstract][Full Text] [Related]
2. Muscone derivative ZM-32 inhibits breast tumor angiogenesis by suppressing HuR-mediated VEGF and MMP9 expression.
Yang LQ; Yu SP; Yang YT; Zhao YS; Wang FY; Chen Y; Li QH; Tian P; Zhu YY; Zhang JG; Lin GQ
Biomed Pharmacother; 2021 Apr; 136():111265. PubMed ID: 33450490
[TBL] [Abstract][Full Text] [Related]
3. HuR promotes breast cancer cell proliferation and survival via binding to CDK3 mRNA.
Zhang Z; Huang A; Zhang A; Zhou C
Biomed Pharmacother; 2017 Jul; 91():788-795. PubMed ID: 28501005
[TBL] [Abstract][Full Text] [Related]
4. Stromal MCP-1 in mammary tumors induces tumor-associated macrophage infiltration and contributes to tumor progression.
Fujimoto H; Sangai T; Ishii G; Ikehara A; Nagashima T; Miyazaki M; Ochiai A
Int J Cancer; 2009 Sep; 125(6):1276-84. PubMed ID: 19479998
[TBL] [Abstract][Full Text] [Related]
5. RKIP regulates CCL5 expression to inhibit breast cancer invasion and metastasis by controlling macrophage infiltration.
Datar I; Qiu X; Ma HZ; Yeung M; Aras S; de la Serna I; Al-Mulla F; Thiery JP; Trumbly R; Fan X; Cui H; Yeung KC
Oncotarget; 2015 Nov; 6(36):39050-61. PubMed ID: 26375811
[TBL] [Abstract][Full Text] [Related]
6. HuR contributes to cyclin E1 deregulation in MCF-7 breast cancer cells.
Guo X; Hartley RS
Cancer Res; 2006 Aug; 66(16):7948-56. PubMed ID: 16912169
[TBL] [Abstract][Full Text] [Related]
7. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
[TBL] [Abstract][Full Text] [Related]
8. Depletion of tristetraprolin in breast cancer cells increases interleukin-16 expression and promotes tumor infiltration with monocytes/macrophages.
Milke L; Schulz K; Weigert A; Sha W; Schmid T; Brüne B
Carcinogenesis; 2013 Apr; 34(4):850-7. PubMed ID: 23241166
[TBL] [Abstract][Full Text] [Related]
9. Role for ezrin in breast cancer cell chemotaxis to CCL5.
Li J; Tu Y; Wen J; Yao F; Wei W; Sun S
Oncol Rep; 2010 Oct; 24(4):965-71. PubMed ID: 20811677
[TBL] [Abstract][Full Text] [Related]
10. The Ribonucleic Complex HuR-MALAT1 Represses CD133 Expression and Suppresses Epithelial-Mesenchymal Transition in Breast Cancer.
Latorre E; Carelli S; Raimondi I; D'Agostino V; Castiglioni I; Zucal C; Moro G; Luciani A; Ghilardi G; Monti E; Inga A; Di Giulio AM; Gorio A; Provenzani A
Cancer Res; 2016 May; 76(9):2626-36. PubMed ID: 27197265
[TBL] [Abstract][Full Text] [Related]
11. CCL5-Mediated Th2 Immune Polarization Promotes Metastasis in Luminal Breast Cancer.
Zhang Q; Qin J; Zhong L; Gong L; Zhang B; Zhang Y; Gao WQ
Cancer Res; 2015 Oct; 75(20):4312-21. PubMed ID: 26249173
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the inflammatory profile of stromal cells in human breast cancer: prominent roles for TNF-α and the NF-κB pathway.
Katanov C; Lerrer S; Liubomirski Y; Leider-Trejo L; Meshel T; Bar J; Feniger-Barish R; Kamer I; Soria-Artzi G; Kahani H; Banerjee D; Ben-Baruch A
Stem Cell Res Ther; 2015 May; 6(1):87. PubMed ID: 25928089
[TBL] [Abstract][Full Text] [Related]
13. Current Evidence and Future Perspectives on HuR and Breast Cancer Development, Prognosis, and Treatment.
Kotta-Loizou I; Vasilopoulos SN; Coutts RH; Theocharis S
Neoplasia; 2016 Nov; 18(11):674-688. PubMed ID: 27764700
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MEG3 Reduces the Ratio of M2/M1 Macrophages Through the HuR/CCL5 Axis in Hepatocellular Carcinoma.
Wei H; Wu X; Huang L; Long C; Lu Q; Huang Z; Huang Y; Li W; Pu J
J Hepatocell Carcinoma; 2024; 11():543-562. PubMed ID: 38496248
[TBL] [Abstract][Full Text] [Related]
15. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis.
Wu X; Gardashova G; Lan L; Han S; Zhong C; Marquez RT; Wei L; Wood S; Roy S; Gowthaman R; Karanicolas J; Gao FP; Dixon DA; Welch DR; Li L; Ji M; Aubé J; Xu L
Commun Biol; 2020 Apr; 3(1):193. PubMed ID: 32332873
[TBL] [Abstract][Full Text] [Related]
16. CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK/STAT3 signaling pathway via CCR5.
Zhu YY; Zhao YC; Chen C; Xie M
Gene; 2022 Feb; 812():146100. PubMed ID: 34864094
[TBL] [Abstract][Full Text] [Related]
17. Silencing of the mRNA-binding protein HuR increases the sensitivity of colorectal cancer cells to ionizing radiation through upregulation of caspase-2.
Badawi A; Hehlgans S; Pfeilschifter J; Rödel F; Eberhardt W
Cancer Lett; 2017 May; 393():103-112. PubMed ID: 28219770
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic overexpression of RNA-binding protein HuR is a marker of poor prognosis in meningioma, and HuR knockdown decreases meningioma cell growth and resistance to hypoxia.
Gauchotte G; Hergalant S; Vigouroux C; Casse JM; Houlgatte R; Kaoma T; Helle D; Brochin L; Rech F; Peyre M; Labrousse F; Vallar L; Guéant JL; Vignaud JM; Battaglia-Hsu SF
J Pathol; 2017 Aug; 242(4):421-434. PubMed ID: 28493484
[TBL] [Abstract][Full Text] [Related]
19. HIF-inducible miR-191 promotes migration in breast cancer through complex regulation of TGFβ-signaling in hypoxic microenvironment.
Nagpal N; Ahmad HM; Chameettachal S; Sundar D; Ghosh S; Kulshreshtha R
Sci Rep; 2015 Apr; 5():9650. PubMed ID: 25867965
[TBL] [Abstract][Full Text] [Related]
20. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
